Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden.

Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden.

Item
http://www.wikidata.org/entity/Q33424116
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis.The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic reviewModeling rheumatoid arthritis using different techniques - a review of model construction and results.Rituximab as first choice for patients with refractory rheumatoid arthritis: cost-effectiveness analysis in Iran based on a systematic review and meta-analysis.The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis.A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs.The impact of a revised EQ-5D population scoring on preference-based utility scores in an inflammatory arthritis cohortIntroduction to economic modeling for clinical rheumatologists: application to biologic agents in rheumatoid arthritis.Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.How to select the right cost-effectiveness model? : A systematic review and stepwise approach for selecting a transferable health economic evaluation model for rheumatoid arthritis.When to use discrete event simulation (DES) for the economic evaluation of health technologies? A review and critique of the costs and benefits of DES.Markov modeling and discrete event simulation in health care: a systematic comparison.Does including informal care in economic evaluations matter? A systematic review of inclusion and impact of informal care in cost-effectiveness studies.Cost-effectiveness analysis of two rituximab retreatment regimens for longstanding rheumatoid arthritis.Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life.
P2860

Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden.

Item
http://www.wikidata.org/entity/Q33424116
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Modeling the cost-effectivenes ...... try data from Southern Sweden.
@ast
Modeling the cost-effectivenes ...... try data from Southern Sweden.
@en
type
label
Modeling the cost-effectivenes ...... try data from Southern Sweden.
@ast
Modeling the cost-effectivenes ...... try data from Southern Sweden.
@en
prefLabel
Modeling the cost-effectivenes ...... try data from Southern Sweden.
@ast
Modeling the cost-effectivenes ...... try data from Southern Sweden.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Modeling the cost-effectivenes ...... try data from Southern Sweden.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921